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The metal mercury is used in thermometers,
fluorescent lamps and batteries; however, over-exposure
to mercury is harmful to human health [1]. In aqueous
ecosystems, this metal is converted into methylmercury,
which accumulates in fish and shellfish. Contaminated
fish and shellfish are the main source of mercury
exposure in humans and methylmercury is readily
absorbed by the alimentary tract. Dietary exposure of
fertile women to mercury increases the risk of
neurological problems in the fetus during pregnancy [2-
4]. In 2004, the U.S. Food and Drug Administration
(FDA) and Environmental Protection Agency (EPA)
recommended that fertile women reduce their
consumption of mercury-contaminated seafood [5]. In
2009, human biomonitoring (HBM) established two
safety criteria for blood mercury levels: HBM I, 5 ɠ/L,
an alert level under which no risk of adverse health
effects, and HBM II, 15 ɠ/L, an action level above which
an increased risk of adverse health effects does exist [6].
Wiggers et al. [7] observed that low level of exposure
to mercury altered vascular activity and induced
endothelial cell dysfunction in animals. De Marco et al,
[8] observed that the blood mercury level of humans was
significantly association with the plasma nitric oxide
level, but the effect of mercury on cardiovascular disease
has not established [9]. Indeed, Guallar et al, [10]
reported that the mercury level in patients suffering from
myocardial infarction was associated with the mortality
rate in this group, whereas Yoshizawa et al. [11] did not
observe this association. It is difficult to understand the
effects of mercury exposure on cardiovascular disease
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Objectives: This study investigated the relationship between the blood mercury concentration and cardiovascular risk
factors in elderly Korean individuals living in coastal areas. 
Methods: The sample consisted of 477 adults (164 males, 313 females) aged 40 to 65 years who visited a Busan health
promotion center from June to September in 2009. The relationship between blood mercury concentration and
cardiovascular risk factors including metabolic syndrome, cholesterol profiles, blood pressure, body mass index (BMI),
waist circumference and waist-to-hip ratio (WHR), was investigated. Variables related to blood mercury concentration
were further evaluated using multiple regression analysis. 
Results: The blood mercury concentration of the study population was 7.99 (range, 7.60 to 8.40) ɠ/L. In males, the blood
mercury concentration was 9.74 (8.92 to 10.63) ɠ/L, which was significantly higher than that in females (7.21, [6.80 to
7.64] ɠ/L). The blood mercury concentration of the study population was related to several cardiovascular risk factors
including low-density lipoprotein (LDL) cholesterol (p=0.044), high-density lipoprotein (HDL) cholesterol (p=0.034), BMI
(p=0.006), waist circumference (p=0.031), and WHR (p<0.001). In males, the blood mercury concentration was
significantly correlated with WHR in the multiple regression analysis.  
Conclusions: In males, the blood mercury concentration was related to waist-to-hip ratio, which is a central obesity index
and cardiovascular risk factor. Our finding suggests that cardiovascular disease risk in males was increased by mercury
exposure via an obesity-related mechanism.
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because fish and shellfish contained unsaturated fats,
which protect against cardiovascular disease and act in a
manner opposite to the adverse effect of mercury
exposure [12,13]. A recent study of mercury exposure
and cardiovascular disease integrated the adverse effects
of mercury exposure and the protective effect of
unsaturated fats [14].
Busan, Korea is located in coastal area and has the
highest standardized mortality ratio (SMR) for
cardiovascular disease compared with other provinces in
Korea: Busan, 31.6; Incheon, 26.5; Ulsan, 24.2; Deagu,
23.9; Daejeon, 20.3; Gwangju, 19.6; and Seoul, 18.7
[15]. We found that the mortality from cardiovascular
disease was higher in coastal areas (Busan, Incheon and
Ulsan) than inland (Deagu, Daejeon, and Gwangju)
areas [15]. However, no study has evaluated the health
effects of mercury exposure on the risk for cardiova-
scular disease in coastal areas. In Korea, research on
mercury has been limited to evaluating the mercury
exposure by region or investigating pathological
mechanisms as heart rate variability [16-21]. Investi-
gations in other countries have compared the
cardiovascular disease risk of subjects with high and low
level of mercury, although studies on factors that are
intermediate between mercury levels and risk for
cardiovascular disease are insufficient [22]. Therefore,
this study evaluates the relationship between the
mercury exposure level and risk for cardiovascular
disease in Korea, by comparing blood mercury
concentrations with presence and parameters of
metabolic syndrome, including cholesterol profiles,
blood pressure, body mass index (BMI), waist
circumference, waist-to-hip ratio (WHR) and fasting
blood sugar levels. 
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I. Study Population
The samples recruited from subjects who had
participated in Korean Genome and Epidemiology Study
(KoGES) and consisted of 477 middle-aged people (40 -
65 years; 164 males, 313 females) who visited a health
promotion center in Busan from June to September,
2009. All the participants were informed of the study
purpose and provided consent for blood sampling and
the use of a personal data. This study was performed
after approval from the Institutional Review Board of the
Dong-A Medical Center. 
II. Questionnaire
A questionnaire survey was administered in face-to-
face interviews. The questionnaire gathered information
on demographic factors (sex and age), smoking status,
drinking habits, menopause, and history of diseases. 
III. Blood Sampling and Anthropometric
Measurements
Blood was sampled after an 8-hour fast and the samples
were transported to a diagnostic center in Seoul. The
cholesterol profiles and fasting blood sugar levels were
analyzed using an enzymatic method. Blood pressure was
checked twice by a trained examiner after participants
rested for 5 minutes in a sitting position. Waist
circumference was determined with a measuring tape
placed midway between the lowest rib and the iliac crest
during expiration. Hip circumference was measured at the
level of the greater trochanters. The WHR equaled the
waist circumference divided by the hip circumference.
Metabolic syndrome was determined by the National
Cholesterol Education Program - Adult Treatment Panel
III (NCEP-ATP III) criteria, using the waist circumference
for Koreans (males, 90 cm; females, 85 cm) [23].
IV. Measuring the Blood Mercury Concentration 
The blood mercury concentration was analyzed using
the double-amalgam method with cold vapor atomic
absorption spectrometry (CV-AAS) using a mercury
analyzer (SP-3DS, NIC, Tokyo, Japan). Blood samples
were collected in an EDTA-treated 3 -mL vacuum tube,
transported on dry ice and stored in a refrigerator at - 70
. Before analysis, the blood samples were thawed
slowly at room temperature and homogenized with a
roller-mixer for 1 hour. The blood samples were
premixed with 0.001 % L-cysteine solution, the hg-BHT,
and the hg-MHT reagents (NIC, Tokyo, Japan) were
added, and the sample was introduced into the analyzer.
After the samples were heated at 650 , the mercury in
the samples was evaporated and captured by gold
amalgam. The captured mercury was evaporated and
introduced into a spectrometer by reheating gold
amalgam at 700 . The blood mercury concentration
was determined by the value absorbed at 253.7 nm. The
L-cysteine solution was produced by mixing 10 mg of
L-cysteine and 2 mL of 60 % nitric acid. A calibration
curve was plotted by 2, 4, 6, and 8- ppb solutions made
from a 1000 ppm mercury standard solution (Wako, $IBOH)VO:PV
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Osaka, Japan) diluted with L-cysteine solution. External
quality control was provided by the Korea Occupational
Safety & Health Agency (KOSHA) and the German
External Quality Assessment Scheme (G-EQUAS). 
V. Statistical Analysis 
Data on blood mercury concentrations had a leftward-
skewed distribution and were analyzed using logarithmic
transformation. The blood mercury concentration was
compared with the cardiovascular risk factors including
blood pressure, cholesterol profiles, BMI, waist
circumference and WHR, using a one-way analysis of
variance (ANOVA). The association between blood
mercury concentration and cardiovascular risk factors
was evaluated using multiple regression analysis. All
statistical analyses were performed with SPSS version
18.0 (SPSS Inc., Chicago, IL, USA), and p < 0.05 was
considered to be statistically significant.
3&46-54
I. General Characteristics of the Study
Population 
The study population consisted of 477 adults including
164 males and 313 females. The mean age of study
population was 53.79  8.11 years and that of male
(54.60  8.69) and female (53.37  7.77) subjects did
not differ significantly. The age distribution and
frequency of fish intake of men and women did not
differ, but smoking status and drinking habits differed
significantly (Table 1).
Table 1. General characteristics of study population                                                                                            n (%)
Variables
Males (n = 164)
MeanSD
Females (n = 313)
MeanSD
p-value
Mean age (y)
40  -  49 
50  -  59
60 >  
Total cholesterol (mg/dL)
Triglycerides (mg/dL)
LDL cholesterol (mg/dL)
HDL cholesterol (mg/dL)
Fasting blood sugar (mg/dL)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Body mass index (kg/m
2)
Waist circumference (cm)
Waist to hip ratio
Smoking
Yes 
No 
Drinking 
Yes 
No
Hair tail (Cutlass fish)
Less than once a week
More than once a week 
Eel
Less than once a week
More than once a week 
Yellow corbina (Croaker, Pacific)
Less than once a week 
More than once a week
Tuna
Less than once a week
More than nce a week 
Sushi (raw fish)
Less than once a week
More than once a week
LDL: low-density lipoprotein, HDL: cholesterol, high-density lipoprotein.
1 The p-value was calculated using t-test to compare males and females, 
2The p-value was calculated using Fisher’s exact test to compare males and
females.
54.60  8.690
052 (31.7)
062 (37.8)
050 (30.5)
194.91  32.17
141.59  79.53
118.80  29.52
047.84  11.10
099.08  21.02
120.02  11.58
078.83  7.210
024.24  2.910
084.01  8.080
000.93  0.050
063 (38.4) 
011 (3.5)0
123 (75.0)
105 (33.5)
103 (62.8)
187 (59.7)
144 (87.8)
285 (91.1)
114 (69.5)
219 (70.0)
153 (93.3)
291 (93.0)
150 (91.5)
298 (95.2)
53.37  7.770
099 (31.6)
141 (45.0)
073 (23.3)
198.71  35.15
113.70  74.20
121.58  32.52
054.48  13.04
092.44  21.40
117.90  12.75
077.88  7.780
023.38  2.990
076.86  8.240
000.82  0.040
101 (61.6)
302 (96.5)
041 (25.0)
208 (66.5)
061 (37.2)
126 (40.3)
020 (12.2)
028 (8.9)0
050 (30.5)
094 (30.0)
011 (6.7)
022 (7.0)
014 (8.5)
015 (4.8)
0.127
1
0.176
2
0.249
1
<0.001
1
0.361
1
<0.001
1
0.001
1
0.075
1
0.194
1
0.003
1
<0.001
1
<0.001
1
<0.001
2
<0.001
2
0.554
2
0.266
2
0.917
2
1.000
2
0.110
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II. Blood Mercury Concentration
The blood mercury concentration of the study
population, males and females were 7.99 (range 7.60 to
8.44), 9.74 (8.92 to 10.63) and 7.21 (6.80 to 7.64) ɠ/L,
respectively. The blood mercury concentration of males
was significantly higher than that of females. The blood
mercury concentrations of subjects in their 40s, 50s, and
60s were 8.87 (7.95 to 9.80), 9.84 (8.98 to 10.71), and
9.06 (8.91 to 9.94) ɠ/L, respectively (Table 2). 
III. Cardiovascular Risk Factors
Comparison of blood mercury with cardiovascular risk
factors showed that low-density lipoprotein (LDL)
cholesterol, high-density lipoprotein (HDL) cholesterol,
BMI, waist circumference and WHR differed
significantly, whereas the prevalence of metabolic
syndrome, total cholesterol, triglycerides, blood
pressure, and fasting blood sugar levels did not differ in
this regard. BMI and WHR were significant variables
among men, whereas LDL cholesterol level, menopause,
and WHR were significant variables among women
(Table 3). 
IV. Association between Cardiovascular Risk
Factors and Blood Mercury Concentration
Multiple regression analysis showed that WHRs
(p<0.001) and LDL cholesterol (p=0.028) levels for the
group who met the HBM I criterion were associated
with blood mercury concentration after adjusting for age,
sex, alcohol intake, and smoking status (Table 4).
Specifically, the WHRs of males whose scores met
HBM I threshold were associated with their blood
mercury concentration (p<0.001).
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In this study, we found that the blood mercury
concentration differed significantly according to the
several cardiovascular risk factors as BMI, LDL
cholesterol, waist circumference and WHR. By contrast,
HDL cholesterol showed no correlation with blood
mercury concentration. The WHRs of males were
significantly related to their blood mercury concent-
rations. Therefore, males with heavy mercury exposure
may be susceptible to cardiovascular disease based on
their WHR. 
Typically, hair, urine and blood are used to evaluate
mercury exposure. The mercury level in hair and urine
reflects long-term exposure, although the mercury
concentration in hair samples is prone to error because of
external contamination such as with dyes, and varies
with length of the hair. It is inconvenient to collect urine
samples to determine mercury levels, and the urine
creatinine level should be 30-300 mg/dL [24]. Although
blood mercury level reflects recent mercury exposure, it
is used widely for monitoring the mercury exposure of
population at risk and for comparison with other
populations. The Second National Human Exposure and
Biomonitoring Examination of Mercury measured the
exposure level of 2369 Koreans at 3.80 (3.66 to 3.93)
ɠ/L, whereas the Third Korean Health Examination
Survey found a level of 4.15 (3.94 to 4.36) ɠ/L in 1997
adults [16-18]. The geometric mean of blood mercury
concentration in our study was 7.99 (7.60 to 8.40) ɠ/L,
which was higher than the range of 3.80 to 4.15 ɠ/L in
the previous Korean National Studies. The blood
mercury concentration of previous studies of coastal
population was 6.54 to 8.63 ɠ/L [19,20], which is
similar to the mean value in our study.
Mahaffey reported that the distributions of mercury
levels in a single country differed by geographic location
and high mercury level in coastal areas were a result of
the ready access to fresh seafood [25]. The HBM has
Table 2. Blood mercury levels of the study population by sex and age
Variable n GM (95% CI)
Mercury concentration by percentiles
5 25 50 75 95 
Total
Sex
Male
Female
Age (y)
40  -  49
50  -  59 
60
477
164
313
151
203
123
7.99 (7.60, 8.40)
9.74 (8.92, 10.63)
7.21 (6.80, 7.64)
8.87 (7.95, 9.80)
9.84 (8.98, 10.71)
9.06 (8.19, 9.94)
3.23
3.91
3.04
2.57
3.52
2.84
5.55
6.77
5.19
5.09
5.86
4.10
7.83
9.66
7.12
7.53
7.96
7.91
11.71
14.59
10.49
10.93
12.08
11.28
18.45
19.56
14.04
15.37
16.60
16.70
GM: Geometric mean, CI: confidence interval.  $IBOH)VO:PV
FUBM
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Table 3. Blood mercury concentration according to cardiovascular risk factors by sex
Total
n GM (95% CI
1) p-value
Male
n GM (95% CI
1) p-value
Female
n GM (95% CI
1) p-value
Total cholesterol (mg/dL)
< 200
200  -  240
> 240
LDL cholesterol (mg/dL)
130 < 130
130  -  160
160 > 160
HDL cholesterol (mg/dL)
< 40 (or 50)
2
40 (or 50)
2
Triglyceride (mg/dL)
130 < 150
150  -  200
160 > 200
Fasting blood sugar (mg/dL)
130 < 110
110  -  126
160 > 126
Systolic blood pressure (mg/dL)
130 < 130
130 130
Diastolic blood pressure (mg/dL)
130 <8 5
130 85
Metabolic syndrome
Yes
No
Body mass index (kg/m
2)
130  < 18.5
18.5  -  25.0
130 25.0
Waist circumference (cm)
< 90 (or 80)
2
90(or 80)
2
Waist-to-hip ratio 
< 0.9 (or 0.8)
2
0.9 - 0.95 (or 0.8-0.85)
2
0.95(or 0.85)
2
Menopause
Yes
No
263
161
53
286
147
44
170
307
362
47
68
423
21
33
327
150
327
150
420
57
11
326
140
425
52
132
240
105
181
132
7.70 (7.20, 8.23)
8.28 (7.62, 8.99)
8.63 (7.21, 10.33)
7.66 (7.19, 8.17)
8.24 (7.55, 9.01)
9.46 (7.86, 11.40)
7.43 (6.86, 8.06)
8.32 (7.81, 8.86)
7.77 (7.34, 8.21)
9.01 (7.58, 10.72)
8.56 (7.39, 9.90)
7.94 (7.52, 8.37)
8.57 (6.86, 10.71)
8.38 (6.91, 10.17)
7.76 (7.30, 8.26)
8.51 (7.82, 9.28)
7.82 (7.35, 8.31)
8.39 (7.68, 9.16)
7.97 (7.57, 8.40)
8.15 (6.90, 9.64)
5.22 (3.67, 7.43)
7.74 (7.30, 8.21)
8.90 (8.09, 9.79)
7.84 (7.44, 8.26)
9.35 (7.96, 10.99)
6.65 (6.13, 7.21)
8.37 (7.80, 8.98)
9.08 (8.08, 10.20)
7.20 (6.64, 7.81)
7.22 (6.65, 7.83)
0.241
0.044
0.034
0.125
0.725
0.090
0.200
0.722
0.006
0.031
0.001
0.974
99
51
14
100
53
11
39
125
110
18
36
135
13
16
106
58
110
54
148
16
5
91
68
129
35
38
79
47
09.16 (8.17, 10.27)
10.48 (8.92, 12.31)
11.46 (8.65, 15.19)
09.31 (8.32, 10.42)
10.21 (8.70, 11.98)
11.65 (8.38, 16.20)
09.67 (8.24, 11.34)
09.75 (8.78, 10.84)
09.12 (8.18, 10.16)
11.66 (8.74, 15.54)
10.87 (9.08, 13.00)
09.62 (8.69, 10.66)
10.63 (8.25, 13.69)
10.04 (8.23, 12.23)
09.58 (8.58, 10.70)
10.02 (8.66, 11.62)
09.72 (8.74, 10.82)
09.76 (8.34, 11.45)
09.48 (8.64, 10.41)
12.43 (9.52, 16.24)
04.87 (2.11, 11.24)
09.04 (8.07, 10.14)
11.31 (9.93, 12.88)
09.51 (8.62, 10.50)
10.61 (8.69, 12.97)
07.05 (6.06, 8.20)
09.68 (8.54, 10.98)
12.77 (10.94, 14.91)
0.210
0.360
0.930
0.100
0.820
0.630
0.960
0.07
0.001
0.31
<0.001
164
110
39
186
94
33
131
182
252
29
32
288
8
17
221
95
217
96
272
41
6
235
72
296
17
94
161
58
181
132
6.94 (6.42, 7.50)
7.42 (6.78, 8.12)
7.80 (6.27, 9.71)
6.90 (6.41, 7.42)
7.32 (6.62, 8.08)
8.84 (7.05, 11.08)
6.88 (6.29, 7.52)
7.45 (6.91, 8.04)
7.25 (6.80, 7.72)
7.68 (6.23, 9.47)
6.54 (5.31, 8.05)
7.25 (6.83, 7.70)
6.04 (4.35, 8.41)
7.07 (5.11, 9.79)
7.02 (6.54, 7.53)
7.68 (6.95, 8.50)
7.00 (6.53, 7.51)
7.70 (6.94, 8.53)
7.25 (6.83, 7.71)
6.91 (5.72, 8.36)
5.53 (3.54, 8.64)
7.29 (6.82, 7.80)
7.10 (6.31, 7.98)
7.21 (6.79, 7.65)
7.20 (5.60, 9.25)
6.49 (5.89, 7.16)
7.79 (7.17, 8.47)
6.89 (6.02, 7.88)
7.20 (6.64, 7.81)
7.22 (6.65, 7.83)
0.343
0.039
0.175
0.452
0.614
0.159
0.136
0.586
0.419
0.991
0.019
0.974
GM: geometric mean, CI: confidence interval, LDL: low-density lipoprotein, HDL: cholesterol, high-density lipoprotein.
1 Mercury concentration, 
2 The values in bracket are the reference for females for HDL cholesterol, waist circumference and waist-to-hip ratio.
Table 4. Multiple regression analysis between blood mercury level and cardiovascular risk factors in the total
population, males and females
Total
1
Variable ǰ p-value
Males
2
Variable ǰ p-value
Females
3
Variable ǰ p-value
HBM I (ɠ/L) <5
5
WHR
LDLc
WHR
LDLc
0.231
-0.006
0.332
0.107
0.1170
0.9570
<0.001
4
0.028
4
WHR
LDLc
WHR
LDLc
0.516
-0.210
0.362
0.094
0.0670
0.4320
<0.001
4
0.2320
WHR
LDLc
WHR
LDLc
0.125
0.037
0.063
0.107
0.380
0.774
0.353
0.102
HBM: human biomonitoring, WHR: Waist-to-hip ratio, LDLc: low-density lipoprotein cholesterol. 
1 The model for the total population was adjusted for age, sex, frequency of fish intake, drinking, and smoking, 
2 The model for males was adjusted for
age, frequency of fish intake, drinking, and smoking, 
3 The model for females was adjusted for age, frequency of fish intake, menopause, drinking and
smoking, 
4 The p-value was statistically significant.#MPPE.FSDVSZ$PODFOUSBUJPOBOE8BJTUUP)JQ3BUJP
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suggested two criteria for mercury exposure: HBM I as
an alert level and HBM II as an action level [6]. The
highest quartile of blood mercury concentrations (14.59
ɠ/L) in males corresponds to HBM II, and the popula-
tion at risk for mercury exposure comprised one-quarter
of the male population. The mean blood mercury level
may have been higher if more participated in our study.
Virtanen et al. [26] reported that Hallgren et al. observed
no association between the mercury level and cardio-
vascular risk because females with low mercury
concentrations participated in their study, and the
distribution of mercury concentrations in the study
population was too narrow to identify the association of
mercury exposure with cardiovascular risk. In our study,
blood mercury levels ranged from 1.48 to 45.54 ɠ/L
and a sufficient numbers of subjects above the criterion
for HBM II participated in our study. 
Among the cardiovascular risk factors, BMI and
WHR, indices of obesity differed according to mercury
concentrations. BMI is related to general adiposity and
WHR is related to central obesity [27]. In a multiple
regression analysis, WHR was associated with blood
mercury concentration, whereas BMI was not.
Additionally, the WHRs of men were correlated with
their mercury levels. This result concurred with a study
of Brazilian natives in a mercury-contaminated area that
found mercury exposure from fish consumption was not
associated with BMI [28]. Hu et al. reported that the
WHRs of men were significantly associated with
cardiovascular disease risk, whereas BMIs were
associated with increased cardiovascular risk in both
sexes [27]. In a study of Faroe islanders and inhabitants
of Nunavik who traditionally consume fish, mercury
exposure was associated with blood pressure as
cardiovascular risk factor in males only [29,30]. In a
European study targeting adult men, an increased risk of
mortality was observed in newly diagnosed patients with
myocardial infarction with high mercury concentrations.
Those results were consistent with our findings of
significant association between blood mercury
concentration and cardiovascular disease risk in males.  
The mercury concentration was reported to be higher
in males than in females. In our study, mercury
concentrations were significantly higher in males than in
females, and an association between mercury exposure
and cardiovascular disease risk was observed in males.
Blood mercury concentration was not significantly
associated with menopause, and we postulate that
estrogen has a limited effect on mercury levels. It is
possible that this limited significance derived from
differences in the alcohol intake and smoking status by
sex, whereas fish consumption was excluded because no
differences in the frequency of fish consumption
according to sex were observed. Kim et al. reported that
drinking alcohol affected mercury concentration [14],
whereas Son et al. reported found no association
between alcohol consumption and mercury concent-
ration [17]. Smoking status has not been associated with
mercury concentration. Therefore, the differences of
mercury concentrations by sex require further investi-
gation. 
Metabolic syndrome is a cardiovascular risk factor and
is related to obesity. We found that the metabolic
syndrome was not correlated with mercury concent-
ration. Park et al. [31] reported that those in highest
quartile of hair-mercury concentration had an increased
risk of metabolic syndrome compared with those in the
lowest quartile. These findings were based on
differences in the mercury concentrations in hair
specimens, which were used as an index of previous
exposure to mercury [32], or on the significance of
differences between the lowest and the highest quartiles
of mercury concentrations. In our results, waist
circumference was the only variable of five diagnostic
criteria for metabolic syndrome (NCEP ATP-III)
associated with mercury level. Thus, metabolic
syndrome was not related to mercury level because a
diagnosis of metabolic syndrome must meet three
additional diagnostic criteria. 
Kim et al. [33] reported that urinary mercury in
children was associated with serum cholesterol and
suggested that heavy metal was as a risk factor for
cardiovascular disease. We found that a blood mercury
concentration in males above HBM I was correlated
with WHR as an index of central obesity. Based on this
finding, we postulated that the risk for cardiovascular
disease of men with a high mercury exposure was
increased by WHR.  However, a significant confounding
effect, that obese subjects may eat more mercury-
contaminated seafood resulting in a high mercury
exposure, should also be considered. Dietary data are
essential to answer this problem, but one weakness of
our study was that its design did not include such data
for analysis. A future study should examine dietary data
and the adverse health effects of mercury exposure. In
addition, no definite pathological mechanism has been
identified to explain the relationship between the
mercury level in males and their WHRs, an index of
central obesity. Further investigations into the
mechanisms related mercury exposure and central
obesity or a cohort study of a population with heavy
mercury exposure should contribute to our $IBOH)VO:PV
FUBM
+1SFW.FE1VCMJD)FBMUI	

understanding of the effect of mercury on cardiovascular
disease.
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